GEn-1124

DRUG2 trials

Sponsors

GEn1E Lifesciences

Conditions

Healthy Adult MaleRespiratory Distress Syndrome, Acute

Phase 1

A Study to Assess the Pharmacokinetics of GEn-1124 After Single Oral Dosing in Healthy Subjects

CompletedNCT07185113

GEn1E LifesciencesHealthy Adult Male

Start: 2025-10-29End: 2025-11-04Updated: 2026-05-15

Phase 2

A Study of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)

RecruitingNCT05795465

GEn1E LifesciencesRespiratory Distress Syndrome, Acute

Start: 2023-04-04End: 2026-12-01Target: 52Updated: 2026-06-23